Global In-Vitro Diagnostics Products Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global In-Vitro Diagnostics Products Market Research Report 2024
In vitro diagnostics are tests that can detect diseases, conditions, or infections. Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home.
In Vitro Diagnostic (IVD) tests are a subset of medical devices. In vitro diagnostic tests are used for in vitro examination of specimens derived from the human body to provide information for screening, diagnosis, or treatment monitoring purposes.
According to Mr Accuracy reports’s new survey, global In-Vitro Diagnostics Products market is projected to reach US$ 103800 million in 2034, increasing from US$ 81060 million in 2022, with the CAGR of 3.5% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole In-Vitro Diagnostics Products market research.
Global In Vitro Diagnostic (IVD) Products key players include Roche, Abbott, Danaher, Siemens Healthineers, Thermo Fisher Scientific, etc. Global top five manufacturers hold a share over 50%.
North America is the largest market, with a share over 40%, followed by Europe and Asia-Pacific, both have a share over 50 percent.
In terms of product, Immuno Diagnostics is the largest segment, with a share over 20%. And in terms of application, the largest application is Hospitals, followed by Laboratory.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global In-Vitro Diagnostics Products market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Roche Diagnostics
Abbott Laboratories
Siemens Healthineers
Becton, Dickson and Company(BD)
Johnson and Johnson
Danaher Corporation
Thermo Fisher Scientific
Sysmex Corporation
Bio-Rad Laboratories
BioMerieux
Qiagen
Ortho-Clinical Diagnostics
Diasorin
Siemens
Segment by Type
In-Vitro Diagnostics Instruments
In-Vitro Diagnostics Reagents
In-Vitro Diagnostics Software
Diabetes
Oncology
Cardiology
Nephrology
Infectious Diseases
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The In-Vitro Diagnostics Products report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
In Vitro Diagnostic (IVD) tests are a subset of medical devices. In vitro diagnostic tests are used for in vitro examination of specimens derived from the human body to provide information for screening, diagnosis, or treatment monitoring purposes.
According to Mr Accuracy reports’s new survey, global In-Vitro Diagnostics Products market is projected to reach US$ 103800 million in 2034, increasing from US$ 81060 million in 2022, with the CAGR of 3.5% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole In-Vitro Diagnostics Products market research.
Global In Vitro Diagnostic (IVD) Products key players include Roche, Abbott, Danaher, Siemens Healthineers, Thermo Fisher Scientific, etc. Global top five manufacturers hold a share over 50%.
North America is the largest market, with a share over 40%, followed by Europe and Asia-Pacific, both have a share over 50 percent.
In terms of product, Immuno Diagnostics is the largest segment, with a share over 20%. And in terms of application, the largest application is Hospitals, followed by Laboratory.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global In-Vitro Diagnostics Products market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Roche Diagnostics
Abbott Laboratories
Siemens Healthineers
Becton, Dickson and Company(BD)
Johnson and Johnson
Danaher Corporation
Thermo Fisher Scientific
Sysmex Corporation
Bio-Rad Laboratories
BioMerieux
Qiagen
Ortho-Clinical Diagnostics
Diasorin
Siemens
Segment by Type
In-Vitro Diagnostics Instruments
In-Vitro Diagnostics Reagents
In-Vitro Diagnostics Software
Segment by Application
Diabetes
Oncology
Cardiology
Nephrology
Infectious Diseases
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The In-Vitro Diagnostics Products report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices